The true cost of chronic pain

Around 3.24 million Australians are suffering from chronic pain daily, costing the economy $139.3 billion in 2018, a new report by Painaustralia has suggested.1 The...

SSRIs for mild cognitive impairment to Alzheimer’s disease

Could selective serotonin reuptake inhibitors (SSRIs) help reduce the burden of Alzheimer’s disease and prevent decline from mild cognitive impairment? An estimated 10% of people...

The mental health researcher

Claire O’Reilly was an intern pharmacist when a patient experience got her thinking about a pharmacist’s role in improving mental health care. Now she’s...

Medicine safety in aged care must be improved

One in five unplanned hospital admissions for aged care residents is the result of inappropriate medicines use, a new report from PSA reveals.

Vaccinating in-house and hub

When the Tasmanian government called for immunisers to staff its COVID-19 vaccination clinics, community pharmacist Robert Beaumont MPS was eager to put his qualifications to good use.

Indigenous communities at risk of antimicrobial resistance

Pharmacists say a new approach is needed to treat the high rates of bacterial infections among remote Indigenous communities after a new study suggested...